Bactolife is a biotechnology company that develops biological solutions to support gut health.
Bactolife has raised $35.2M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
Bactolife's investors include Bill & Melinda Gates Foundation, Novo Holdings, Export and Investment Fund, Cross-Border Impact Ventures, Novo Seeds.
Bactolife is headquartered in Lyngby, Denmark.
Bactolife is a biotechnology company that develops biological solutions to support gut health.
Bactolife is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bactolife — Funding & Investors." VCBacked, January 6, 2026, https://www.vcbacked.co/company/bactolife. Accessed July 31, 2026.
VCBacked. (2026). Bactolife — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/bactolife
{{cite web |title=Bactolife — Funding & Investors |url=https://www.vcbacked.co/company/bactolife |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated